Presented by David Rattner, M.D.
disclosures–1:45
citation–3:39 https://www.ncbi.nlm.nih.gov/pubmed/16894027
IOM definition of conflict of interest–5:15
conflicts of interest we don’t disclose–5:46
fellowships–9:42
ability to influence–13:50
objective journalism–16:22
scholarly work or bias?–16:40 https://www.ncbi.nlm.nih.gov/pubmed/18413880
https://jama.jamanetwork.com/article.aspx?articleid=185567
Click to access relmanangell.pdf
commercialism–18:10 https://www.ncbi.nlm.nih.gov/pubmed/?term=17473299
https://www.ncbi.nlm.nih.gov/pubmed/19474385
https://www.ncbi.nlm.nih.gov/pubmed/21306245
sponsored research–21:26
industry sponsorship–24:30
scientific misconduct–25:10
marketing–27:09
FDA–30:12
CME–32:35
rational approach–35:51
Keyword(s): ABS, ACCME, ACGME, bariatric surgery, bias, biomedical research, CME, COI, EBM, Ethicon Endosurgery, ethics, FDA, fellowships, FFS, FLS, healthcare costs, industry, innovation, IOM, Karl Storz lecture, marketing, medical device companies, MIS, NEJM, NIH grant, pharmaceutical companies, professional organizations, PROVE-IT study, reimbursement, scientific fraud